← Open Payments lookup

THOMAS MCCORMACK: Open Payments

NPI 1740298728 · BOGART, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$21,356 in 184 payments from 20 companies in 2025. Trend: 2023 $27,435 · 2024 $33,054 · 2025 $21,356

Honoraria: $14,600Food & beverage: $3,415Travel & lodging: $3,282Education: $59
CompanyPaymentsAmount
Axsome Therapeutics, Inc.16$11,347
Supernus Pharmaceuticals, Inc.23$7,381
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$409
Neurocrine BioSciences, Inc.20$375
Otsuka America Pharmaceutical, Inc.11$212
Vanda Pharmaceuticals Inc.10$204
ABBVIE INC.17$201
Alkermes, Inc.7$160
Lundbeck LLC8$157
Janssen Pharmaceuticals, Inc7$156

Products named: Auvelity, Qelbree, CAPLYTA, INGREZZA, REXULTI, FANAPT, VRAYLAR, ABILIFY ASIMTUFII.

Industry payments across GA — which companies pay providers there.